Telomir shareholders elect four directors, ratify auditor at 2026 annual meeting

Telomir Pharmaceuticals, Inc.

47,129,480 shares voted (68.53% of 68,774,954 outstanding) at Sept 11, 2026 meeting.
Directors elected: Erez Aminov, Matthew Whalen, Edward MacPherson, Matthew Del Giudice, M.D.; votes for ranged from 41.2M to 43.4M.
Ratification of Salberg & Company, P.A. as independent auditor passed with 46,998,583 votes for, 69,548 against.
Adjournment proposal approved: 44,841,042 for, 2,271,263 against, 17,175 abstained.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.